Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2025 ,inter alia, to consider and approve Audited Financial Results and recommendation ....
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Ltd has informed the stock exchanges that its Board of Directors will meet on Monday, May 5, 2025, at the company's registered office. The key agenda items are: (1) approval of Audited Financial Results (both standalone and consolidated) for the fourth quarter and full financial year ended March 31, 2025, along with taking on record the Statutory Auditors' report; and (2) consideration and recommendation of a Final Dividend, if any, on equity shares of face value Rs. 10 each for FY25. The filing is made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements. No financial figures or specific business updates are disclosed in this intimation, which is a routine advance notice ahead of the earnings announcement.
This is a routine regulatory intimation with no immediate impact on shareholders. Investors should watch for the actual Q4FY25 results and any dividend declaration post the May 5 board meeting, which could influence near-term stock sentiment.